Hemera was recently featured in Cytotherapy, the official journal of the International Society for Cell & Gene Therapy, as one of the most innovative global players in the field of cell therapy.
The article, titled “Smart Cell Therapy: An Industry Perspective on Macrophages as Living Drugs” , explores the potential of macrophage-based cell therapies—an emerging frontier in immunotherapy.
The mention of scientific contributions by Hemera’s team—Sissi Dolci, Ilaria Decimo, Francesco Bifari, Massimo Locati, and Guido Fumagalli—within such a high-level context is a significant recognition of the scientific and innovative value of our technology. It also confirms the leading role our research is taking in the field of regenerative medicine.